Clinical Trial Update: Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a regimen of fludarabine, busulfan, antithymocyte globulin, and donor stem cell transplant in patients with treatment-refracto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• BUSULFAN (Busulfan)
• Donor stem cell transplant
• Fludarabine (Fludarabine)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED